Guangdong Sirio Pharma Co., Ltd. logo

Guangdong Sirio Pharma Co., Ltd. (300791)

Market Closed
10 Aug, 06:57
XSHE XSHE
¥
17. 31
+0.36
+2.1239%
¥
7.01B Market Cap
- P/E Ratio
2% Div Yield
1.86M Volume
- Eps
¥ 16.95
Previous Close
Add Transaction
Day Range
16.8 17.34
Year Range
15.4 26.45
Want to track 300791 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300791 closed yesterday higher at ¥17.31, an increase of 2.1239% from Friday's close, completing a monthly increase of 8.5947% or ¥1.37. Over the past 12 months, 300791 stock lost -33.0626%.
300791 pays dividends to its shareholders, with the most recent payment made on Jun 05, 2026. The next estimated payment will be in In 9 months on Jun 05, 2027 for a total of ¥0.13.
The last earnings report, released on Apr 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2085%, based on the last three reports.
Guangdong Sirio Pharma Co., Ltd. has completed 4 stock splits, with the recent split occurring on May 27, 2025.
The company's stock is traded on one exchange.

300791 Chart

People also search for

Tecon Biology Co., Ltd.
¥ 7.18
-1.3736%
Shandong Yisheng Livestock Co., Ltd.
¥ 10.52
+5.3053%
Chongqing Baiya Sanitary Products Co., Ltd.
¥ 14.24
-2.2649%
CQ Pharmaceutical Holding Inc.
¥ 5.59
+1.4519%
Three Squirrels Inc.
¥ 17.85
-0.8333%

Guangdong Sirio Pharma Co., Ltd. (300791) FAQ

What is the stock price today?

The current price is ¥17.31.

On which exchange is it traded?

Guangdong Sirio Pharma Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300791.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, the market cap is 7.01B.

Has Guangdong Sirio Pharma Co., Ltd. ever had a stock split?

Guangdong Sirio Pharma Co., Ltd. had 4 splits and the recent split was on May 27, 2025.

Guangdong Sirio Pharma Co., Ltd. Profile

Food Products Industry
Consumer Staples Sector
Mr. Peiqing Li CEO
XSHE Exchange
CNE100003NB0 ISIN
CN Country
2,776 Employees
5 Jun 2026 Last Dividend
27 May 2025 Last Split
- IPO Date

Overview

Sirio Pharma Co., Ltd. is a global contract manufacturer with a focus on the dietary supplement industry. The company has carved a niche for itself by offering an extensive range of development and manufacturing services tailored to the nuanced needs of the nutraceutical market. Founded in 1993 and headquartered in Shantou, China, Sirio Pharma has built a reputation for its comprehensive suite of solutions that cater to the complex demands of supplement production and packaging. Their expertise spans across various formulations, ensuring that clients receive end-to-end services under one roof.

Products and Services

  • Softgel Dietary Supplements:

    These are easy-to-swallow gels containing various dietary supplements. Sirio Pharma specializes in the manufacture of both traditional and vegetarian softgels, catering to a wide range of dietary preferences and needs.

  • Vegetarian Softgel:

    Specifically designed for consumers who prefer vegetarian options, these softgels are made without any animal-derived ingredients, offering an ethical and healthy alternative to traditional gelatin softgels.

  • Nutraceutical Gummies:

    A popular choice for both children and adults, nutraceutical gummies are a tasty way to consume dietary supplements. Sirio Pharma produces gummies that come in various flavors, shapes, and formulations, making supplements more enjoyable to take.

  • Probiotic Products:

    With a focus on digestive health, Sirio Pharma manufactures probiotic supplements designed to maintain and restore healthy gut flora. These products come in various forms, ensuring versatility and ease of consumption for the end-user.

  • Tablet and Powder Products:

    This category includes a wide range of dietary supplements in tablet and powder forms. Tailored to meet the specific health and wellness needs of consumers, these products are designed for easy incorporation into daily routines.

  • Capsules:

    Sirio Pharma provides capsules that are an alternative to softgels, offering another form of oral delivery for dietary supplements. Capsules are available in different sizes and formulations, according to the requirements of their clients.

  • Functional Beverages:

    Expanding beyond solid forms, the company also delves into liquid solutions with its functional beverages. These drinks are infused with vitamins, minerals, or other beneficial ingredients, offering a convenient and enjoyable way to consume dietary supplements.

  • Primary and Final Packaging:

    Complementing their manufacturing services, Sirio Pharma offers complete packaging solutions. This includes both primary packaging directly in contact with the product and final packaging for retail presentation, ensuring products are market-ready.

Contact Information

Address: No. 83, Taishan Road, Shantou, China, 515000
Phone: 86 02 0314 20016